Clinical and sociodemographic characteristics associated with thick melanomas: A Population-based, Case-case study in France

Archives of Dermatology

Volumn 148, Issue 12, 2012, Pages 1370-1376

  Grange, Florent ^a   Barbe, Coralie ^a   Aubin, Francois ^b   Lipsker, Dan ^c   Granel Brocard, Florence ^d   Velten, Michel ^e   Dalac, Sophie ^f   Truchetet, François ^e   Michel, Catherine ^e   Mitschler, Audrey ^g   Arnoult, Gwendoline ^h   Buemi, Antoine ^e   Dalle, Stéphane ⁱ   Bernard, Philippe ^a   Woronoff, Anne Sophie ^j  

^a SERVICE DE DERMATOLOGIE   (France)

^b HÔPITAL SAINT JACQUES   (France)

^c HÔPITAL CIVIL   (France)

^d CHU NANCY BRABOIS   (France)

^e Service de Dermatologie Hôpital Brabois ^*  (France)

^f HÔPITAL DU BOCAGE   (France)

^g Pasteur Hospital   (France)

^h HÔPITAL MAISON BLANCHE   (France)

ⁱ HÔTEL DIEU   (France)

^j UNIVERSITY HOSPITAL OF BESANÇON   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER LOCALIZATION; CANCER SIZE; CAUSAL ATTRIBUTION; CLINICAL EVALUATION; EDUCATIONAL STATUS; EMPLOYMENT STATUS; FAMILY LIFE; FEMALE; FRANCE; GEOGRAPHIC DISTRIBUTION; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MELANOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; SKIN ULCER; SMOKING HABIT; URBAN RURAL DIFFERENCE; AGE; CANCER STAGING; MIDDLE AGED; PATHOLOGY; SKIN NEOPLASMS; SOCIOECONOMICS;

ADULT; AGE FACTORS; AGED; FEMALE; FRANCE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; SEX FACTORS; SKIN NEOPLASMS; SOCIOECONOMIC FACTORS;

EID: 84871371969     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2012.2937     Document Type: Article

References (44)

1. Heenan PJ, English DR, Holman CD, Armstrong BK. Survival among patients with clinical stage I cutaneous malignant melanoma diagnosed in Western Australia in 1975/1976 and 1980/1981. Cancer. 1991;68(9):2079-2087.
2. Lasithiotakis KG, Leiter U, Eigentler T, et al. Improvement of overall survival of patients with cutaneous melanoma in Germany, 1976-2001: which factors contributed? Cancer. 2007;109(6):1174-1182. (Pubitemid 46435398)
3. Verdecchia A, Francisci S, Brenner H, et al; EUROCARE-4 Working Group. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol. 2007;8(9):784-796. (Pubitemid 47321601)
4. Criscione VD, Weinstock MA. Melanoma thickness trends in the United States, 1988-2006. J Invest Dermatol. 2010;130(3):793-797.
5. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma, I: common and atypical naevi. Eur J Cancer. 2005;41(1):28-44. (Pubitemid 40029657)
6. Graham S, Marshall J, Haughey B, et al. An inquiry into the epidemiology of melanoma. Am J Epidemiol. 1985;122(4):606-619. (Pubitemid 15023236)
7. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma, II: sun exposure. Eur J Cancer. 2005;41(1):45-60. (Pubitemid 40029658)
8. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma, III: family history, actinic damage and phenotypic factors. Eur J Cancer. 2005;41(14):2040-2059. (Pubitemid 41337946)
9. MacKie RM, Freudenberger T, Aitchison TC. Personal risk-factor chart for cutaneous melanoma. Lancet. 1989;2(8661):487-490. (Pubitemid 19209152)
10. Tucker MA.Melanoma epidemiology. Hematol Oncol Clin North Am. 2009;23(3):383-395.
11. Montella M, Crispo A, Grimaldi M, et al. An assessment of factors related to tumor thickness and delay in diagnosis of melanoma in southern Italy. Prev Med. 2002;35(3):271-277.
12. Fisher NM, Schaffer JV, Berwick M, Bolognia JL. Breslow depth of cutaneous melanoma: impact of factors related to surveillance of the skin, including prior skin biopsies and family history of melanoma. J Am Acad Dermatol. 2005;53(3):393-406. (Pubitemid 41195959)
13. Nagore E, Oliver V, Botella-Estrada R, Moreno-Picot S, Guillén C, Fortea JM. Clinicopathological analysis of 1571 cutaneous malignant melanomas in Valencia, Spain: factors related to tumour thickness. Acta Derm Venereol. 2006;86(1):50-56. (Pubitemid 46939789)
14. Richard MA, Grob JJ, Avril MF, et al. Delays in diagnosis and melanoma prognosis (I): the role of patients. Int J Cancer. 2000;89(3):271-279. (Pubitemid 30430744)
15. Richard MA, Grob JJ, Avril MF, et al. Delays in diagnosis and melanoma prognosis (II): the role of doctors. Int J Cancer. 2000;89(3):280-285. (Pubitemid 30430745)
16. Baumert J, Plewig G, Volkenandt M, Schmid-Wendtner M-H. Factors associated with a high tumour thickness in patients with melanoma. Br J Dermatol. 2007;156(5):938-944. (Pubitemid 46642845)
17. Pennie ML, Soon SL, Risser JB, Veledar E, Culler SD, Chen SC. Melanoma outcomes for Medicare patients: association of stage and survival with detection by a dermatologist vs a nondermatologist. Arch Dermatol. 2007;143(4):488-494. (Pubitemid 46631647)
18. Van Durme DJ, Ferrante JM, Pal N, Wathington D, Roetzheim RG, Gonzalez EC. Demographic predictors of melanoma stage at diagnosis. Arch Fam Med. 2000;9(7):606-611.
19. Geller AC, Elwood M, Swetter SM, et al. Factors related to the presentation of thin and thick nodular melanoma from a population-based cancer registry in Queensland Australia. Cancer. 2009;115(6):1318-1327.
20. Schwartz JL, Wang TS, Hamilton TA, Lowe L, Sondak VK, Johnson TM. Thin primary cutaneous melanomas: associated detection patterns, lesion characteristics, and patient characteristics. Cancer. 2002;95(7):1562-1568.
21. Chamberlain AJ, Fritschi L, Giles GG, Dowling JP, Kelly JW. Nodular type and older age as the most significant associations of thick melanoma in Victoria, Australia. Arch Dermatol. 2002;138(5):609-614.
22. Carli P, De Giorgi V, Palli D, et al Italian Multidisciplinary Group on Melanoma. Dermatologist detection and skin self-examination are associated with thinner melanomas: results from a survey of the Italian Multidisciplinary Group on Melanoma. Arch Dermatol. 2003;139(5):607-612. (Pubitemid 36576376)
23. Mandalà M, Imberti GL, Piazzalunga D, et al. Association of socioeconomic status with Breslow thickness and disease-free and overall survival in stage I-II primary cutaneous melanoma. Mayo Clin Proc. 2011;86(2):113-119.
24. Geller AC, Swetter SM, Oliveria S, Dusza S, Halpern AC. Reducing mortality in individuals at high risk for advanced melanoma through education and screening. J Am Acad Dermatol. 2011;65(5)(suppl 1):S87-S94.
25. Barbe C, Hibon E, Vitry F, Le Clainche A, Grange F. Clinical and pathological characteristics of melanoma: a population-based study in a French regional population. J Eur Acad Dermatol Venereol. 2012;26(2):159-164.
26. Grange F. Epidemiology of cutaneous melanoma: descriptive data in France and Europe. Ann Dermatol Venereol. 2005;132(12, pt 1):975-982. (Pubitemid 43182451)
27. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001;19(16):3635-3648. (Pubitemid 32786276)
28. Grange F, Vitry F, Granel-Brocard F, et al. Variations in management of stage I to stage III cutaneous melanoma: a population-based study of clinical practices in France. Arch Dermatol. 2008;144(5):629-636. (Pubitemid 351724423)
29. Durbec F, Vitry F, Granel-Brocard F, et al. The role of circumstances of diagnosis and access to dermatological care in early diagnosis of cutaneous melanoma: a population-based study in France. Arch Dermatol. 2010;146(3):240-246.
30. Lipsker DM, Hedelin G, Heid E, Grosshans EM, Cribier BJ. Striking increase of thin melanomas contrastswith stable incidence of thick melanomas. Arch Dermatol. 1999;135(12):1451-1456.
31. MacKie RM, Hole D, Hunter JA, et al The Scottish Melanoma Group. Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94. BMJ. 1997;315(7116):1117-1121. (Pubitemid 27470306)
32. Harrison RA, Haque AU, Roseman JM, Soong SJ. Socioeconomic characteristics and melanoma incidence. Ann Epidemiol. 1998;8(5):327-333. (Pubitemid 28380472)
33. Reyes-Ortiz CA, Goodwin JS, Freeman JL, Kuo Y-F. Socioeconomic status and survival in older patients with melanoma. J Am Geriatr Soc. 2006;54(11):1758-1764. (Pubitemid 44665217)
34. Singh SD, Ajani UA, Johnson CJ, et al. Association of cutaneous melanoma incidence with area-based socioeconomic indicators-United States, 2004-2006. J Am Acad Dermatol. 2011;65(5)(suppl 1):S58-S68.
35. Kalkhoran S, Milne O, Zalaudek I, et al. Historical, clinical, and dermoscopic characteristics of thin nodular melanoma. Arch Dermatol . 2010;146(3):311-318.
36. Weinstock MA. Cutaneous melanoma: public health approach to early detection. Dermatol Ther. 2006;19(1):26-31.
37. Durbec F, Martin L, Derancourt C, Grange F. Melanoma of the hand and foot: epidemiological, prognostic and genetic features: a systematic review. Br J Dermatol. 2012;166(4):727-739.
38. de Vries E, Nijsten TEC, Visser O, et al. Superior survival of females among 10,538 Dutch melanoma patients is independent of Breslow thickness, histologic type and tumor site. Ann Oncol. 2008;19(3):583-589. (Pubitemid 351325683)
39. Demierre M-F, Chung C, Miller DR, Geller AC. Early detection of thick melanomas in the United States: beware of the nodular subtype. Arch Dermatol. 2005;141(6):745-750. (Pubitemid 41001075)
40. Liu W, Dowling JP, Murray WK, et al. Rate of growth in melanomas: characteristics and associations of rapidly growing melanomas. Arch Dermatol. 2006;142(12):1551-1558. (Pubitemid 44969210)
41. Chamberlain AJ, Fritschi L, Kelly JW. Nodular melanoma: patients' perceptions of presenting features and implications for earlier detection. J Am Acad Dermatol. 2003;48(5):694-701. (Pubitemid 36583278)
42. Girardi S, Gaudy C, Gouvernet J, Teston J, Richard MA, Grob J-J. Superiority of a cognitive education with photographs over ABCD criteria in the education of the general population to the early detection of melanoma: a randomized study. Int J Cancer. 2006;118(9):2276-2280.
43. Lipsker D. Growth rate, early detection, and prevention of melanoma: melanoma epidemiology revisited and future challenges. Arch Dermatol. 2006;142(12):1638-1640. (Pubitemid 44969222)
44. Lipsker D, Engel F, Cribier B, Velten M, Hedelin G. Trends in melanoma epidemiology suggest three different types of melanoma. Br J Dermatol. 2007;157(2):338-343. (Pubitemid 47083865)